Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerrie Leanne McDonald

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Neuro-Oncology|December 17, 2010
Brain tumors and drivingKerrie Leanne McDonald
Molecular Neurobiology|April 30, 2013
Current progress for the use of miRNAs in glioblastoma treatmentAmanda Tivnan, Kerrie Leanne McDonald
Journal of Cancer Research and Therapeutics|June 24, 2017
Is neuroglial antigen 2 a potential contributor to cilengitide response in glioblastoma?Hatice Sevim Nalkiran, Kerrie Leanne McDonald
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 19, 2017
How immunotherapies are targeting the glioblastoma immune environmentJonathan Felthun, Rajesh Reddy, Kerrie Leanne McDonald
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Neuro-Oncology|December 17, 2010
Brain tumors and drivingKerrie Leanne McDonald
Molecular Neurobiology|April 30, 2013
Current progress for the use of miRNAs in glioblastoma treatmentAmanda Tivnan, Kerrie Leanne McDonald
Journal of Cancer Research and Therapeutics|June 24, 2017
Is neuroglial antigen 2 a potential contributor to cilengitide response in glioblastoma?Hatice Sevim Nalkiran, Kerrie Leanne McDonald
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 19, 2017
How immunotherapies are targeting the glioblastoma immune environmentJonathan Felthun, Rajesh Reddy, Kerrie Leanne McDonald
Pageof 1